Breaking News Instant updates and real-time market news.

2021-03-01 05:15:20 AMADY Amadeus IT Group $0.00 / + (+0.00%) 05:15 03/01/21 03/01 05:15 03/01/21 05:15	Amadeus IT Group upgraded to Neutral from Reduce at Oddo BHF Oddo BHF analyst Nicolas David upgraded Amadeus IT Group to Neutral from Reduce with a EUR 57 price target.	02 Mar
AMADY Amadeus IT Group $0.00 / + (+0.00%) 01/25/21 Credit Suisse Amadeus IT Group price target raised to EUR 47.73 at Credit Suisse 01/15/21 Deutsche Bank Amadeus IT Group price target raised to EUR 55 from EUR 45 at Deutsche Bank 01/07/21 Barclays Amadeus IT Group downgraded to Underweight from Equal Weight at Barclays 12/10/20 Morgan Stanley Amadeus IT Group price target raised to EUR 72 from EUR 67 at Morgan Stanley

2021-03-01 05:15:20

AMADY

Amadeus IT Group

$0.00 / + (+0.00%)

05:15

03/01/21

03/01

05:15

03/01/21

05:15

Amadeus IT Group upgraded to Neutral from Reduce at Oddo BHF

Oddo BHF analyst Nicolas David upgraded Amadeus IT Group to Neutral from Reduce with a EUR 57 price target.

02
Mar

AMADY Amadeus IT Group

$0.00 / + (+0.00%)

01/25/21 Credit Suisse: Amadeus IT Group price target raised to EUR 47.73 at Credit Suisse

01/15/21 Deutsche Bank: Amadeus IT Group price target raised to EUR 55 from EUR 45 at Deutsche Bank

01/07/21 Barclays: Amadeus IT Group downgraded to Underweight from Equal Weight at Barclays

12/10/20 Morgan Stanley: Amadeus IT Group price target raised to EUR 72 from EUR 67 at Morgan Stanley

TODAY'S FREE FLY STORIES

Periodicals	Siemens Healthineers weighing sale of ultrasound unit, Bloomberg says » 11:28 04/12/21 04/12 11:28 04/12/21 11:28 SMMNY Siemens Healthineers $28.08 / +0.125 (+0.45%) The ultrasound unit that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings SMMNY Siemens Healthineers $28.08 / +0.125 (+0.45%) 10/15/20 Varian stockholders approve combination with Siemens Healthineers SMMNY Siemens Healthineers $28.08 / +0.125 (+0.45%) 03/16/21 HSBC Siemens Healthineers upgraded to Buy from Hold at HSBC 02/23/21 UBS Siemens Healthineers price target raised to EUR 46 from EUR 40 at UBS 02/08/21 Berenberg Siemens Healthineers price target raised to EUR 55 from EUR 54 at Berenberg 02/08/21 Deutsche Bank Siemens Healthineers price target raised to EUR 46 from EUR 43 at Deutsche Bank SMMNY Siemens Healthineers $28.08 / +0.125 (+0.45%) 01/26/21 Siemens Healthineers raises FY21 adjusted EPS view to EUR1.63-1.82 01/26/21 Siemens Healthineers sees Q1 adjusted EPS EUR0.49 vs. EUR0.36 last year
Options	Kinross Gold call volume above normal and directionally bullish » 11:25 04/12/21 04/12 11:25 04/12/21 11:25 KGC Kinross Gold $7.30 / -0.11 (-1.48%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events Options KGC Kinross Gold $7.30 / -0.11 (-1.48%) 02/10/21 Kinross Gold sees FY21 CapEx $900M, plus or minus 5% 02/10/21 Kinross Gold sees FY21 gold equivalent production 2.4M ounces 01/05/21 Gold Standard Ventures announces senior leadership changes 10/20/20 Kinross Gold provides long-term production profile KGC Kinross Gold $7.30 / -0.11 (-1.48%) 02/11/21 Barclays Kinross Gold price target raised to $10 from $9 at Barclays 02/10/21 JPMorgan Kinross initiated with Overweight, added to Focus List at JPMorgan 02/08/21 Stifel Kinross Gold price target lowered to C$14.50 from C$14.75 at Stifel 01/11/21 National Bank Kinross Gold price target lowered to C$17.25 from C$18 at National Bank KGC Kinross Gold $7.30 / -0.11 (-1.48%) 02/10/21 Kinross Gold reports Q4 adjusted EPS 27c, consensus 22c 11/04/20 Kinross Gold reports Q3 EPS ,25c consensus 21c KGC Kinross Gold $7.30 / -0.11 (-1.48%) 10/19/20 Kinross Gold considers selling North, South America gold mines, G&M reports 05/12/21 Kinross Gold - KGC KGC Kinross Gold $7.30 / -0.11 (-1.48%) 04/09/21 Kinross Gold call volume above normal and directionally bullish 02/19/21 Kinross Gold put volume heavy and directionally bearish 02/17/21 Kinross Gold call volume above normal and directionally bullish 02/01/21 Kinross Gold call volume above normal and directionally bullish
Conference/Events	JPMorgan retail/dept stores analyst holds analyst/industry conference call » 11:25 04/12/21 04/12 11:25 04/12/21 11:25 Retail/Dept Stores &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Conference/Events	The Executives Club of Chicago holds a virtual meeting » 11:20 04/12/21 04/12 11:20 04/12/21 11:20 The Executives Club of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	Roth says Rapt Therapeutics' AACR presentations highlight broad potential » 11:19 04/12/21 04/12 11:19 04/12/21 11:19 RAPT Rapt Therapeutics $20.40 / -0.54 (-2.58%) Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly RAPT Rapt Therapeutics $20.40 / -0.54 (-2.58%) 03/22/21 Rapt completes enrollment in clinical trial of RPT193 for atopic dermatitis 11/16/20 Rapt Therapeutics reports data from ongoing Phase 1/2 trial of FLX475 10/14/20 Rapt Therapeutics appoints Lisa Butterfield, Lawrence Fong to SAB RAPT Rapt Therapeutics $20.40 / -0.54 (-2.58%) 03/12/21 H.C. Wainwright Rapt Therapeutics price target raised to $32 from $30 at H.C. Wainwright 11/17/20 BMO Capital Rapt Therapeutics price target lowered to $45 from $51 at BMO Capital 10/21/20 BMO Capital Rapt Therapeutics price target raised to $51 from $40 at BMO Capital 09/02/20 Roth Capital Rapt rise after Gilead deal with Jounce 'warranted,' says Roth Capital RAPT Rapt Therapeutics $20.40 / -0.54 (-2.58%) 03/11/21 Rapt Therapeutics reports Q4 EPS (52c), consensus (59c) 11/16/20 Rapt Therapeutics reports Q3 EPS (60c), consensus (57c) RAPT Rapt Therapeutics $20.40 / -0.54 (-2.58%) 11/16/20 Fly Intel: Wall Street's top stories for Monday 11/16/20 Fly Intel: Wall Street's top stories at midday

Hot Stocks	Tian Ruixiang Holdings Ltd (Class A Stock) trading resumes 11:18 04/12/21 04/12 11:18 04/12/21 11:18 TIRX Tian Ruixiang $92.80 / +1 (+1.09%) ShowHide Related Items >><< Company News Syndicate On The Fly TIRX Tian Ruixiang $92.80 / +1 (+1.09%) 11:06 Today Tian Ruixiang Holdings Ltd (Class A Stock) trading halted, volatility trading pause 03/08/21 Tian Ruixiang Holdings Ltd (Class A Stock) trading resumes 03/08/21 Tian Ruixiang Holdings Ltd (Class A Stock) trading halted, volatility trading pause 03/03/21 Tian Ruixiang Holdings Ltd (Class A Stock) trading resumes 27 Jan TIRX Tian Ruixiang $92.80 / +1 (+1.09%) 01/31/21 Opening Day: Qualtrics jumps 40% in trading debut
Conference/Events	Economic Club of New York to host a virtual meeting » 11:17 04/12/21 04/12 11:17 04/12/21 11:17 GS Goldman Sachs $333.90 / +3.05 (+0.92%) Goldman Sachs President… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GS Goldman Sachs $333.90 / +3.05 (+0.92%) 04/11/21 Fly Intel: Top five weekend stock stories 03/25/21 Fed plans to end temporary restrictions on bank dividends, share repurchases 03/23/21 New York finds no fair lending violations on Apple Card by Goldman Sachs 03/19/21 Fed says supplementary leverage ratio to expire as scheduled on March 31 GS Goldman Sachs $333.90 / +3.05 (+0.92%) 04/09/21 JMP Securities Goldman Sachs price target raised to $400 from $338 at JMP Securities 04/08/21 Citi Goldman Sachs price target raised to $390 from $370 at Citi 04/07/21 Barclays Goldman Sachs price target raised to $420 from $392 at Barclays 04/01/21 Fly Intel: Top five analyst downgrades GS Goldman Sachs $333.90 / +3.05 (+0.92%) 01/19/21 Goldman Sachs reports Q4 EPS $12.08, consensus $7.47 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports 10/14/20 Goldman Sachs reports Q3 EPS $9.68, consensus $5.57 10/13/20 Notable companies reporting before tomorrow's open GS Goldman Sachs $333.90 / +3.05 (+0.92%) 04/10/21 Goldman Sachs had strong pandemic, still room to run, Barron's says 04/09/21 China's Didi Chuxing files confidentially for U.S. IPO, Bloomberg says 04/08/21 Sen. Brown seeks details of banks' ties to Archegos Capital, CNBC reports 04/08/21 Employees at Goldman's Marcus business 'quitting in droves,' BI reports GS Goldman Sachs $333.90 / +3.05 (+0.92%) 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/29/21 Analysts upgrade ViacomCBS, GSX Techedu as selloff in shares continues 03/19/21 Fly Intel: Wall Street's top stories for Friday 03/19/21 Fly Intel: Wall Street's top stories at midday 04/14/21 Goldman Sachs - GS 14:15 Today Goldman Sachs President Participates in Virtual Event 04/29/21 Goldman Sachs Group Inc. GS Goldman Sachs $333.90 / +3.05 (+0.92%) 04/09/21 Unusually active option classes on open April 9th 03/30/21 Unusually active option classes on open March 30th 03/29/21 Unusually active option classes on open March 29th 03/26/21 Unusually active option classes on open March 26th
Technical Analysis	NASDAQ market internals summary » 11:17 04/12/21 04/12 11:17 04/12/21 11:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 10:17 Today NASDAQ market internals summary 04/09/21 NASDAQ market internals summary 04/09/21 NASDAQ market internals summary 04/09/21 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 11:16 04/12/21 04/12 11:16 04/12/21 11:16 $NYE NYSE Market Internals / + Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 10:16 Today NYSE market internals summary 04/09/21 NYSE market internals summary 04/09/21 NYSE market internals summary 04/09/21 NYSE market internals summary
Conference/Events	Federal Reserve Bank of Boston president speaks on the economy » 11:15 04/12/21 04/12 11:15 04/12/21 11:15 Boston Federal Reserve… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Conference/Events	Truist medical devices analysts hold an analyst/industry conference call » 11:13 04/12/21 04/12 11:13 04/12/21 11:13 Medical Devices Analysts,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Clear Blue Smiles partners with GreenSky Patient Solutions » 11:13 04/12/21 04/12 11:13 04/12/21 11:13 GSKY GreenSky $6.12 / -0.06 (-0.97%) GreenSky and Clear Blue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events GSKY GreenSky $6.12 / -0.06 (-0.97%) 02/17/21 GreenSky trading resumes 02/17/21 GreenSky trading halted, volatility trading pause 02/08/21 GreenSky names Jennifer Russell Chief Credit Officer 11/17/20 GreenSky CEO buys 1.1M shares of common stock GSKY GreenSky $6.12 / -0.06 (-0.97%) 03/11/21 Citi GreenSky price target raised to $5 from $4 at Citi 11/16/20 Citi GreenSky price target lowered to $3.50 from $4 at Citi 11/06/20 Wolfe Research GreenSky initiated with an Underperform at Wolfe Research 11/05/20 Citi GreenSky assumed with a Sell at Citi GSKY GreenSky $6.12 / -0.06 (-0.97%) 03/10/21 GreenSky sees FY21 revenue approximately $584M, consensus $584.18M 03/10/21 GreenSky reports Q4 EPS 11c, consensus 6c 01/12/21 GreenSky sees FY22 revenue approximately $660M, adjusted EBITDA $200M 01/12/21 GreenSky sees FY20 revenue approximately $520M, consensus $518.95M GSKY GreenSky $6.12 / -0.06 (-0.97%) 11/23/20 Fly Insider: Organogenesis, Estee Lauder among weeks notable insider trades 11/17/20 Fly Intel: After-Hours Movers 11/09/20 Fly Intel: After-Hours Movers 05/24/21 Global Technology, Media & Communications Virtual Conference
Options	Call buyer slides into Valvoline position vs 50k share delta hedge » 11:10 04/12/21 04/12 11:10 04/12/21 11:10 VVV Valvoline $26.85 / +0.36 (+1.36%) Call buyer slides into… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VVV Valvoline $26.85 / +0.36 (+1.36%) 12/02/20 Valvoline to acquire 27 quick-lube locations in seven states 11/12/20 Valvoline announces $100M share repurchase 11/12/20 Valvoline raises quarterly dividend to 12.5c per share from 11.25c 11/10/20 Monro announces renewed supply agreement with Valvoline VVV Valvoline $26.85 / +0.36 (+1.36%) 03/22/21 Citi Valvoline price target raised to $32 from $28 at Citi 02/08/21 Citi Valvoline price target raised to $28 from $25 at Citi 02/04/21 Monness Crespi Valvoline price target raised to $30 from $26 at Monness Crespi 01/11/21 Seaport Global Valvoline downgraded to Neutral from Buy at Seaport Global VVV Valvoline $26.85 / +0.36 (+1.36%) 02/03/21 Valvoline still sees FY21 adjusted EPS $1.57-$1.67, consensus $1.64 02/03/21 Valvoline reports Q1 adjusted EPS 41c, consensus 36c 10/28/20 Valvoline reports Q4 adjusted EPS 46c, consensus 36c
Hot Stocks	Merck KGaA reports objective response rate of 36% for berzosertib » 11:06 04/12/21 04/12 11:06 04/12/21 11:06 MKGAY Merck KGaA $38.36 / + (+0.00%) Merck KGaA announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals MKGAY Merck KGaA $38.36 / + (+0.00%) 04/01/21 F-star Therapeutics announces third option exercised by Merck KGaA 02/03/21 Merck KGaA announces FDA approval of Tepmetko in metastatic lung cancer 01/25/21 Pfizer, Merck KGaA announce EC approval of Bavencio for UC patients 01/20/21 Merck KGaA discontinues clinical trial for bintrafusp alfa in lung cancer MKGAY Merck KGaA $38.36 / + (+0.00%) 02/10/21 Berenberg Merck KGaA initiated with a Hold at Berenberg 01/04/21 JPMorgan Merck KGaA upgraded to Overweight from Neutral at JPMorgan 11/20/20 Pareto Merck KGaA upgraded to Buy from Hold at Pareto 11/16/20 AlphaValue Merck KGaA upgraded to Add from Reduce at AlphaValue MKGAY Merck KGaA $38.36 / + (+0.00%) 03/15/21 BioNTech recruits Novartis, Sanofi to boost vaccine production, WSJ reports
Hot Stocks	Tian Ruixiang Holdings Ltd (Class A Stock) trading halted, volatility trading pause 11:06 04/12/21 04/12 11:06 04/12/21 11:06 TIRX Tian Ruixiang $95.29 / +3.49 (+3.80%) ShowHide Related Items >><< Company News Syndicate On The Fly TIRX Tian Ruixiang $95.29 / +3.49 (+3.80%) 03/08/21 Tian Ruixiang Holdings Ltd (Class A Stock) trading resumes 03/08/21 Tian Ruixiang Holdings Ltd (Class A Stock) trading halted, volatility trading pause 03/03/21 Tian Ruixiang Holdings Ltd (Class A Stock) trading resumes 03/03/21 Tian Ruixiang Holdings Ltd (Class A Stock) trading halted, volatility trading pause 27 Jan TIRX Tian Ruixiang $95.29 / +3.49 (+3.80%) 01/31/21 Opening Day: Qualtrics jumps 40% in trading debut

Options	Square call volume above normal and directionally bullish » 11:05 04/12/21 04/12 11:05 04/12/21 11:05 SQ Square $259.68 / -2.08 (-0.79%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SQ Square $259.68 / -2.08 (-0.79%) 04/06/21 Crypto Council for Innovation launches with Square,Coinbase, Fidelity as members 03/04/21 Square director sells 8.2K shares of common stock 03/04/21 Square to acquire majority stake in Tidal for $297M in cash, stock 03/01/21 Square says Square Financial Services has begun operations SQ Square $259.68 / -2.08 (-0.79%) 04/09/21 Credit Suisse Square price target raised to $290 from $270 at Credit Suisse 04/07/21 Fly Intel: Top five analyst initiations 04/07/21 Oddo BHF Square initiated with a Neutral at Oddo BHF 04/07/21 Barclays Barclays boosts Square target to $330 on potential for international upside SQ Square $259.68 / -2.08 (-0.79%) 02/23/21 Square reports Q4 adjusted EPS 32c, consensus 24c 02/23/21 Notable companies reporting after market close 11/05/20 Square reports Q3 adjusted EPS 34c, consensus 16c 11/05/20 Square reports Q3 revenue $3.03B, consensus $2.07B SQ Square $259.68 / -2.08 (-0.79%) 02/24/21 Square CFO says Cash App saw surge in new bitcoin buyers in January, CNBC says 02/19/21 'Heard on the Street' highlights PayPal, Square among crypto-exposure names 12/24/20 Square held talks to acquire music service Tidal, Bloomberg reports 11/25/20 DOJ wants Intuit to sell Credit Karma tax unit to approve deal, CNBC says SQ Square $259.68 / -2.08 (-0.79%) 04/09/21 The Intersection: Crypto and Wall Street This Week 03/31/21 Apple upgrade, Shopify initiation among today's top calls on Wall Street 03/04/21 Fly Intel: Wall Street's top stories for Thursday 03/04/21 Fly Intel: Wall Street's top stories at midday 05/24/21 Global Technology, Media & Communications Virtual Conference 05/06/21 Square - SQ SQ Square $259.68 / -2.08 (-0.79%) 04/07/21 Unusually active option classes on open April 7th 03/02/21 Square call volume above normal and directionally bullish 02/23/21 Square options imply 13.4% move in share price post-earnings 12/22/20 Unusual call flow in option market yesterday
General news	European Fixed Income Summary: » 11:05 04/12/21 04/12 11:05 04/12/21 11:05 $ECON Economic Data / + European Fixed Income… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><<
Recommendations	iTeos Therapeutics' EOS-448 'competitive' in TIGIT class, says Piper Sandler » 11:02 04/12/21 04/12 11:02 04/12/21 11:02 ITOS iTeos Therapeutics $25.41 / -1.495 (-5.56%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events ITOS iTeos Therapeutics $25.41 / -1.495 (-5.56%) 04/11/21 iTeos announces preliminary data from ongoing Phase 1/2a trial of EOS-448 11/12/20 iTeos Therapeutics appoints Matthew Roden to board of directors ITOS iTeos Therapeutics $25.41 / -1.495 (-5.56%) 04/09/21 Piper Sandler AACR abstracts a 'win' for iTeos Therapeutics, says Piper Sandler 04/05/21 Piper Sandler Piper Sandler continues to recommend iTeos Therapeutics into data 03/25/21 Wedbush iTeos Therapeutics price target raised to $52 from $46 at Wedbush 10/07/20 Baird iTeos Therapeutics initiated with an Outperform at Baird ITOS iTeos Therapeutics $25.41 / -1.495 (-5.56%) 03/24/21 iTeos Therapeutics reports Q4 EPS (43c), consensus (42c) 11/12/20 iTeos Therapeutics reports Q3 EPS (48c), consensus (36c) 24 Jul 08:00 Today iTeos Therapeutics - ITOS
Recommendations	Provention Bio price target lowered to $22.50 from $35 at Chardan » 11:02 04/12/21 04/12 11:02 04/12/21 11:02 PRVB Provention Bio $8.00 / +0.01 (+0.13%) Chardan analyst Gbola… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events PRVB Provention Bio $8.00 / +0.01 (+0.13%) 04/08/21 Provention Bio trading resumes 04/08/21 Provention Bio receives FDA notification of deficiencies in BLA for teplizumab 04/08/21 Provention Bio trading halted, news pending 03/03/21 Provention Bio's teplizumab shows efficacy in delaying type 1 diabetes PRVB Provention Bio $8.00 / +0.01 (+0.13%) 04/09/21 SVB Leerink Provention Bio price target lowered to $16 from $26 at SVB Leerink 04/09/21 RBC Capital Provention Bio cut to Sector Perform at RBC Capital after teplizumab FDA notice 04/09/21 Cantor Fitzgerald Provention Bio price target lowered to $25 from $27 at Cantor Fitzgerald 04/09/21 RBC Capital Provention Bio downgraded to Sector Perform from Outperform at RBC Capital PRVB Provention Bio $8.00 / +0.01 (+0.13%) 02/25/21 Provention Bio reports Q4 EPS (58c), consensus (50c) 11/05/20 Provention Bio reports Q3 EPS (56c), consensus (43c) 14 Jan 18 Jun PRVB Provention Bio $8.00 / +0.01 (+0.13%) 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/09/21 Fly Intel: Wall Street's top stories at midday 04/09/21 Fly Intel: Pre-market Movers 04/08/21 Fly Intel: After-Hours Movers 05/27/21 Endocrinologic & Metabolic Drugs Advisory Committee Meeting 07/02/21 PDUFA Date for Teplizumab 05/12/21 Provention Bio, Inc.
Recommendations	Sage Therapeutics essential tremor data 'a win,' says Piper Sandler » 10:58 04/12/21 04/12 10:58 04/12/21 10:58 SAGE Sage Therapeutics $74.43 / -2.3 (-3.00%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SAGE Sage Therapeutics $74.43 / -2.3 (-3.00%) 07:09 Today Sage, Biogen announce Kinetic study in essential tremor met primary endpoint 03/17/21 Sage Therapeutics' zuranolone for depression shows positive Phase 3 results 03/16/21 Sage Therapeutics announces departure of COO Mike Cloonan 01/07/21 Sage Therapeutics plans to advance SAGE-319, SAGE-421 to preclinical studies SAGE Sage Therapeutics $74.43 / -2.3 (-3.00%) 04/07/21 Piper Sandler Sage Therapeutics assumed with an Overweight at Piper Sandler 02/26/21 Mizuho Sage Therapeutics downgraded to Neutral from Buy at Mizuho 02/25/21 Oppenheimer Sage Therapeutics price target raised to $102 from $90 at Oppenheimer 02/25/21 H.C. Wainwright Sage Therapeutics price target raised to $86 from $74 at H.C. Wainwright SAGE Sage Therapeutics $74.43 / -2.3 (-3.00%) 02/24/21 Sage Therapeutics reports Q4 EPS $18.19, consensus (35c) 11/05/20 Sage Therapeutics reports Q3 EPS ($2.03), consensus ($2.39) SAGE Sage Therapeutics $74.43 / -2.3 (-3.00%) 12/04/20 Delta, United, Boeing downgrades among today's top calls on Wall Street 11/27/20 Fly Intel: Wall Street's top stories for Friday 11/27/20 Fly Intel: Pre-market Movers 04/15/21 Sage Therapeutics

Options	Nautilus put volume heavy and directionally bearish » 10:55 04/12/21 04/12 10:55 04/12/21 10:55 NLS Nautilus $16.12 / -0.455 (-2.75%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NLS Nautilus $16.12 / -0.455 (-2.75%) 04/05/21 Nautilus announces John Goelz as Chief Supply Chain Officer 03/18/21 Nautilus planning 5-year CAGR of 10%, including 6% on equipment side 03/18/21 Nautilus aims for $1B in revenue, 2M digital members by FY26 03/09/21 Nautilus appoints Ellen Raim as chief people officer NLS Nautilus $16.12 / -0.455 (-2.75%) 03/19/21 Craig-Hallum Nautilus price target lowered to $25 from $30 at Craig-Hallum 03/19/21 Roth Capital Nautilus price target lowered to $26 from $29 at Roth Capital 03/19/21 William Blair Nautilus 2026 margin target sent shares down 10%, says William Blair 03/19/21 Craig-Hallum Nautilus price target lowered to $25 from $30 at Craig-Hallum NLS Nautilus $16.12 / -0.455 (-2.75%) 02/22/21 Nautilus sees Q1 net sales growth of 55%-75% over last year 02/22/21 Nautilus reports Q4 EPS 89c, consensus 75c 11/09/20 Nautilus sees FY20 revenue $540M-$565M, consensus $448.61M 11/09/20 Nautilus reports Q3 adjusted EPS 87c, consensus 32c NLS Nautilus $16.12 / -0.455 (-2.75%) 11/25/20 Peloton shipping delays may benefit Nautilus, WSJ reports NLS Nautilus $16.12 / -0.455 (-2.75%) 02/23/21 Fly Intel: Wall Street's top stories for Tuesday 02/23/21 Fly Intel: Wall Street's top stories at midday 02/23/21 Fly Intel: Pre-market Movers 02/22/21 Fly Intel: After-Hours Movers NLS Nautilus $16.12 / -0.455 (-2.75%) 03/26/21 Nautilus put volume heavy and directionally bearish 03/15/21 Nautilus call volume above normal and directionally bullish 03/03/21 Unusual call flow in option market yesterday 03/02/21 Aggressive buyer sweeps October calls in Nautilus
Conference/Events	Microsoft to host conference call » 10:55 04/12/21 04/12 10:55 04/12/21 10:55 NUAN Nuance $53.30 / +7.705 (+16.90%) , MSFT Microsoft $255.41 / -0.32 (-0.13%) Conference call to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NUAN MSFT NUAN Nuance $53.30 / +7.705 (+16.90%) 09:00 Today Nuance trading resumes 08:56 Today Nuance to resume trading at 09:00ET 08:55 Today Nuance jumps 23% to $56.00 after Microsoft confirms takeover bid 08:35 Today Microsoft to acquire Nuance for $56.00 per share in cash, or $19.7B MSFT Microsoft $255.41 / -0.32 (-0.13%) 08:55 Today Nuance jumps 23% to $56.00 after Microsoft confirms takeover bid 08:35 Today Microsoft to acquire Nuance for $56.00 per share in cash, or $19.7B 08:32 Today Microsoft to acquire Nuance for $56.00 per share in cash 07:56 Today Unisys names Dwayne Allen as Chief Technology Officer NUAN MSFT NUAN Nuance $53.30 / +7.705 (+16.90%) 08:30 Today Stifel Microsoft a 'logical buyer' of Nuance, says Stifel 07:36 Today B. Riley Nuance possible takeout positive for peer LivePerson, says B. Riley 07:29 Today Wedbush Nuance deal would be 'trophy' for Microsoft, says Wedbush 03/10/21 Wedbush Nuance added to Best Ideas List at Wedbush MSFT Microsoft $255.41 / -0.32 (-0.13%) 08:30 Today Stifel Microsoft a 'logical buyer' of Nuance, says Stifel 07:36 Today B. Riley Nuance possible takeout positive for peer LivePerson, says B. Riley 07:29 Today Wedbush Nuance deal would be 'trophy' for Microsoft, says Wedbush 07:11 Today BMO Capital Microsoft price target raised to $280 from $270 at BMO Capital NUAN MSFT NUAN Nuance $53.30 / +7.705 (+16.90%) 02/08/21 Nuance raises FY21 revenue view to $1.34B-$1.38B from $1.33B-$1.37B 02/08/21 Nuance sees Q2 EPS 14c-18c, consensus 18c 02/08/21 Nuance reports Q1 adjusted EPS 20c, consensus 18c 11/18/20 Nuance says FY21 guidance reflects continuing Enterprise revenue growth MSFT Microsoft $255.41 / -0.32 (-0.13%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/26/21 Microsoft reports Q2 EPS $2.03, consensus $1.64 01/26/21 Notable companies reporting after market close 10/27/20 Microsoft sees Q2 Productivity and Business Processes revenue $12.75B-$13B NUAN MSFT NUAN Nuance $53.30 / +7.705 (+16.90%) 04/11/21 Microsoft in talks to buy Nuance for about $56 per share, Bloomberg says MSFT Microsoft $255.41 / -0.32 (-0.13%) 04/11/21 Microsoft in talks to buy Nuance for about $56 per share, Bloomberg says 04/09/21 Hackers scraped data of 500M LinkedIn users, Insider reports 04/06/21 Facebook, Apple and Niantic see a future in augmented -reality glasses, WSJ says 04/01/21 LinkedIn testing Clubhouse competitor, Business Insider reports NUAN MSFT NUAN Nuance $53.30 / +7.705 (+16.90%) 09:03 Today Fly Intel: Pre-market Movers 03/08/21 Microsoft, Salesforce rise as analysts get more bullish on software sector 02/08/21 Fly Intel: After-Hours Movers 11/19/20 Fly Intel: Wall Street's top stories for Thursday MSFT Microsoft $255.41 / -0.32 (-0.13%) 09:03 Today Fly Intel: Pre-market Movers 04/07/21 Game On: An exclusive talk with 'Genesis Noir' developer Feral Cat Den 04/05/21 Roblox jumps as several Wall Street analysts initiate coverage with a Buy 03/31/21 Fly Intel: Wall Street's top stories for Wednesday 00:00 Today Nvidia GTC-21 Virtual Conference 05/24/21 Global Technology, Media & Communications Virtual Conference 11:00 Today Microsoft - MSFT NUAN MSFT NUAN Nuance $53.30 / +7.705 (+16.90%) 04/07/21 Nuance call volume above normal and directionally bullish 03/23/21 Nuance call buyer realizes 9% same-day gains 02/08/21 Nuance options imply 10.5% move in share price post-earnings MSFT Microsoft $255.41 / -0.32 (-0.13%) 04/06/21 Microsoft call buyer realizes 130% same-day gains 01/26/21 Microsoft options imply 6.7% move in share price post-earnings 12/17/20 Notable open interest changes for December 17th 11/11/20 Notable open interest changes for November 11th
Syndicate	Recursion Pharmaceuticals 18M share IPO price range $16.00-$18.00 » 10:49 04/12/21 04/12 10:49 04/12/21 10:49 RXRX Recursion Pharmaceuticals / + Goldman Sachs and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Earnings	SBA sees at least $22.5M more straight-line revenue in 2021 than prior guidance » 10:47 04/12/21 04/12 10:47 04/12/21 10:47 SBAC SBA Communications $277.53 / +2.03 (+0.74%) , VZ Verizon $57.60 / +0.14 (+0.24%) In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SBAC VZ SBAC SBA Communications $277.53 / +2.03 (+0.74%) 10:02 Today Verizon announces deals with Crown Castle and SBA Communications 02/22/21 Dish signs master lease agreement with SBA Communications 02/02/21 PG&E unit sells rights to 700 towers to SBA Communications for $973M 01/24/21 Fly Intel: Top five weekend stock stories VZ Verizon $57.60 / +0.14 (+0.24%) 10:02 Today Verizon announces deals with Crown Castle and SBA Communications 04/09/21 Franklin Wireless responds to Verizon Jetpack recall 04/08/21 Verizon recalls 2.5M Ellipsis Jetpack hotspots imported by Franklin Wireless 04/08/21 Verizon, Honda test how 5G can improve safety for connected, autonomous vehicles SBAC VZ SBAC SBA Communications $277.53 / +2.03 (+0.74%) 08:01 Today Jefferies SBA Communications initiated with a Buy at Jefferies 03/25/21 KeyBanc SBA Communications upgraded to Overweight from Sector Weight at KeyBanc 03/18/21 Wolfe Research SBA Communications initiated with an Outperform at Wolfe Research 03/05/21 Raymond James SBA Communications upgraded to Strong Buy from Outperform at Raymond James VZ Verizon $57.60 / +0.14 (+0.24%) 03/30/21 KeyBanc KeyBanc sees partnership with Google as neutral to T-Mobile 03/24/21 Tigress Financial Verizon upgraded to Buy at Tigress Financial 03/24/21 Tigress Financial Verizon upgraded to Buy from Neutral at Tigress Financial 03/12/21 Morgan Stanley T-Mobile highlighted 'impressive' cash flow ramp at event, says Morgan Stanley SBAC VZ SBAC SBA Communications $277.53 / +2.03 (+0.74%) 02/22/21 SBA Communications sees FY21 AFFO $10-$10.41, consensus $10.12 02/22/21 SBA Communications reports Q4 AFFO $2.49, consensus $2.44 11/02/20 SBA Communications raises FY20 AFFO view to $9.27-$9.50 from $8.94-$9.33 11/02/20 SBA Communications reports Q3 AFFO $2.38, consensus $2.32 VZ Verizon $57.60 / +0.14 (+0.24%) 01/27/21 Crown Castle,Verizon expand relationship with long term 5G small cell commitment 01/26/21 Verizon sees FY21 EPS $5.00-$5.15, consensus $4.98 01/26/21 Verizon reports Q4 adjusted EPS $1.21, consensus $1.17 01/25/21 Notable companies reporting before tomorrow's open SBAC VZ SBAC SBA Communications $277.53 / +2.03 (+0.74%) 01/23/21 SBA, Equinix among names to buy in year of digital infrastructure, Barron's says VZ Verizon $57.60 / +0.14 (+0.24%) 03/27/21 Verizon, IBM among stocks to build income stream for long haul, Barron's says 03/24/21 Verizon Media to rebrand media franchises as Yahoo products, Axios reports 02/25/21 Verizon tops 5G spectrum bidders with $45.5B pledge in FCC auction, WSJ reports 02/05/21 U.S. states urge FCC to investigate Verizon's plan to buy Tracfone, Reuters says VZ VZ Verizon $57.60 / +0.14 (+0.24%) 03/24/21 GameStop downgrade, Estee Lauder upgrade among today's top calls on Wall Street 03/12/21 Fly Intel: Wall Street's top stories for Friday 02/25/21 Analysts cut Verizon, AT&T ratings after companies spend big in FCC auction 02/25/21 Lowe's, Square upgrades among today's top calls on Wall Street 00:00 Today Nvidia GTC-21 Virtual Conference 05/24/21 Global Technology, Media & Communications Virtual Conference 04/21/21 Verizon - VZ 04/26/21 SBA Communications - SBAC 05/13/21 Verizon Communications Inc. 05/13/21 SBA Communications Corporation VZ VZ Verizon $57.60 / +0.14 (+0.24%) 03/12/21 Verizon call volume above normal and directionally bullish 02/25/21 Unusually active option classes on open February 25th 02/23/21 Verizon call volume above normal and directionally bullish 02/17/21 Verizon call volume above normal and directionally bullish
Syndicate	Biomea Fusion 7.5M share IPO price range $15.00-$17.00 » 10:46 04/12/21 04/12 10:46 04/12/21 10:46 BMEA Biomea Fusion / + JPMorgan, Jefferies and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial

Events

Earnings calls, analyst events, roadshows and more

Today at 11:30

6-Month Bill Auction Government Event
Today at 11:30

3-Year Note Auction Government Event
OTTR
Today at 11:30

Otter Tail Corporation Firm Sponsored Meetings
GNK
Today at 12:00

Genco Shipping - GNK Conference Calls
WDAY
Today at 12:00

Workday, Inc. Firm Sponsored Meetings

Virtual Meeting
Today at 13:00

10-Year Note Auction Government Event
Today at 13:00

Fed Reserve Bank President Speaks on US Economy Government Event

Virtual Event
Today at 13:00

Minority Depository Institutions (MDI) Subcommittee Holds Virtual Meeting Government Event

Virtual Meeting
Today at 13:00

3-Month Bill Auction Government Event
NVDA
Today at 13:00

NVIDIA Corp. Firm Sponsored Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares
Fri	No deals

View All Syndicate Announcements »

Amadeus IT Group upgraded to Neutral from Reduce at Oddo BHF

TODAY'S FREE FLY STORIES

Get Full Fly Access